Best tirzepatide providers in Illinois, 2026
The best tirzepatide providers in Illinois use prescribers licensed in Illinois and pharmacies licensed by the Illinois Department of Financial and Professional Regulation, and they show the full price up front. Online, compounded tirzepatide costs $139 to $399 a month, all in, at the 13 of the 14 programs in our price index that sell it in Illinois. NexLife is $139 a month on the 12-month plan or $169 month to month, the same at every dose, with no membership fee. Brand-name Zepbound is $299 to $449 a month at LillyDirect ($449 from 7.5 mg, with a refill within 45 days). Illinois Medicaid covers Zepbound only for obstructive sleep apnea, not for weight loss alone. Looking for tirzepatide near you? From Chicago and Aurora to Rockford and Springfield, you can start online and, if a provider prescribes it, have it shipped to your door. Compounded tirzepatide isn’t FDA-approved. Prices checked Nov. 1, 2026; Illinois rules, Nov. 2, 2026.
NexLife publishes this guide and is one of the programs in it. Every price and rule links to its source.
Tirzepatide in Illinois at a glance
| Option | Per month | Good to know |
|---|---|---|
| NexLife, compounded tirzepatide | $139 or $169 | $139 on the 12-month plan, $169 month to month, every dose. No membership fee. |
| Compounded, 13 online programs | $139–$399 | The 13 of the 14 in our index that sell it in Illinois. Not FDA-approved. |
| Zepbound at LillyDirect | $299–$449 | $449 from 7.5 mg needs a refill within 45 days ($499–$699 otherwise). Medication only. |
| Zepbound through Ro | $448–$598 | Includes Ro’s $149 monthly membership |
| Medicare GLP-1 Bridge | $50 | Zepbound KwikPen, not vials; eligible Part D enrollees, with prior authorization |
| Illinois Medicaid | Not covered | For weight loss alone; sleep apnea only |
| NexLife Price Match Guarantee†. Already on compounded tirzepatide with another licensed provider, and paying less? We match your regular monthly price. How it works · Who qualifies | ||
Prices come from each program’s own site, LillyDirect and CMS. Illinois’s rules come from its own agencies and laws.
- Tell us about youAbout 3 minutes of health questions
- A licensed provider decidesYou’re prescribed only if it’s right for you
- Your partner pharmacy shipsUsually within 1 to 2 business days, free
Key takeaways
- Illinois Medicaid covers Zepbound only for obstructive sleep apnea, not for weight loss alone (checked Nov. 2, 2026).
- Illinois’s state employee plan covers GLP-1 drugs for weight loss only with criteria.
- A pharmacy outside Illinois needs an Illinois license to ship you a prescription; you can look it up in minutes.
- Your prescriber needs an Illinois license to treat you there.
- Heat is the local risk: Carbondale reached 86°F or more on 87 of 122 summer days in 2026; Rockford on 30.
- At NexLife, it’s $139 a month on the 12-month plan or $169 month to month, at every dose: $68 under the $237 median of the 14 programs in our GLP-1 price index.
Who are the best tirzepatide providers in Illinois?
It depends on what you need. Look for a program that serves Illinois, uses prescribers licensed in Illinois and a licensed pharmacy, and shows the all-in price. Here’s the best fit for each need, from our price index and the brand-name routes, with the catch for each, ours included (checked Nov. 1, 2026).
NexLife
The same from 2.5 mg to 15 mg, with a licensed provider, a nutrition plan, a 1:1 coaching call and real people 24/7. No membership fee.
The catch: month to month, $169 is more than PreventiveMD’s $139. Switching with an active prescription? The Price Match† covers a lower regular monthly price; prepaid rates elsewhere aren’t matched.
PreventiveMD
No membership or visit fees, and it serves Illinois.
The catch: not offered in six other states and D.C., so check before you move.
Mochi Health
Medication from $90 a month, by dose, plus a $79 monthly membership.
The catch: the price rises with your dose.
Zepbound at LillyDirect
$399 at 5 mg, and $449 from 7.5 mg to 15 mg with a refill within 45 days.
The catch: miss the 45 days and it’s $499 at 7.5 mg or $699 at 10 to 15 mg. Your prescriber’s visit is separate.
Medicare GLP-1 Bridge
The Zepbound KwikPen for eligible enrollees, with prior authorization.
The catch: it doesn’t cover vials, and it runs from July 1, 2026, to Dec. 31, 2027.
Prices are each program’s published national prices; a few limit what they sell in some states, so confirm before you pay. Full index with sources: GLP-1 price index. Nationally, side by side: best tirzepatide providers. By dose: tirzepatide price by dose. All 14, month by month: compounded tirzepatide price.
Compare
How much do the top 10 tirzepatide providers charge in Illinois?
Month to month and all in, compounded tirzepatide costs $139 to $399 a month at these providers in Illinois, checked Nov. 1, 2026. Brand-name Zepbound is $299 to $449 a month at LillyDirect ($449 from 7.5 mg, with a refill within 45 days), or from $448 a month with the $149 membership at Hims or Ro.
| Provider | Month to month, all in | As your dose rises | Membership fee | Lowest prepaid rate | Best for |
|---|---|---|---|---|---|
| Compounded tirzepatide (not FDA-approved) | |||||
| PreventiveMDCompounded | $139 | Stays $139 | None | – | Month to month, no membership fee |
| Mochi HealthCompounded | $169at the lowest dose | Rises with dose | $79/moincluded in the $169 | $49/momembership on 12 months, plus medication | Obesity-medicine doctors |
| NexLifeCompounded · NexLife publishes this guide | $169 | Stays $169 | None | $139/mo12-month plan | Publisher of this guide |
| Ondra HealthCompounded | $219 | Stays $219 | None | $142/mo12 months, $1,699 upfront; some pharmacies | Plan lengths from 1 to 12 months |
| Rx.comCompounded | $285 | Stays $285 | None | $149/mo12 months, $1,788 upfront | No automatic renewals |
| NoomCompounded | $299after a $149 first month | Not listed by dose | Program included | $897billed every 12 weeks | Most coaching |
| Remedy MedsCompounded | $399per 4 weeks, after $279 at first | Stays $399 | None listed | None listed | Unlimited clinician access |
| Brand-name Zepbound (FDA-approved) | |||||
| LillyDirectZepbound | $299–$449per 28-day supply ($449 from 7.5 mg needs a refill within 45 days; otherwise $499–$699) | $299 to $449 | None | None listed | Zepbound at Lilly’s price |
| HimsZepbound | From $448with the $149 membership | Varies by dose | $149/mo$39 the first month | None listed | 24/7 provider messaging |
| RoZepbound | $448–$598with the $149 membership | $448 to $598 | $149/mo$39 the first month | $74/momembership, prepaid a year, plus medication | Insurance checks |
| NexLife Price Match Guarantee†. Already on compounded tirzepatide with another licensed provider, and paying less? We match your regular monthly price. How it works · Who qualifies | |||||
Prices are each company’s published prices; a few programs limit where they sell, so confirm before you pay. All 14 compounded programs, with sources: GLP-1 price index.
Pharmacies
Compounding pharmacies licensed to mail compounded injections to Illinoisans
Only pharmacies licensed by the Illinois Department of Financial and Professional Regulation may mail you compounded tirzepatide. A pharmacy outside Illinois needs an Illinois nonresident pharmacy license to mail prescriptions here, applying with its latest inspection report. It must follow Illinois law for Illinois patients, print a toll-free pharmacist number on each label and, since March 30, 2026, have an Illinois-licensed pharmacist-in-charge. Sterile compounding follows USP <797>.
225 ILCS 85/16a; 68 Ill. Adm. Code 1330.550 (nonresident pharmacies); 68 Ill. Adm. Code 1330.640 (sterile compounding) · source
- Check it in a minute. Look up any pharmacy on Illinois’s pharmacy license lookup before you pay.
- Match your label. The pharmacy’s name and address on your box should match its Illinois license.
- NexLife’s partner pharmacies. Absolute Pharmacy (Lutz, FL) and Boudreaux’s New Drug Store (Lake Charles, LA). We send Illinois prescriptions only to the ones with the licenses Illinois requires.
“Generally, state boards of pharmacy have primary responsibility for the day-to-day oversight of state-licensed pharmacies that are not registered with FDA as outsourcing facilities.”
U.S. Food and Drug Administration, Compounding and the FDA: Questions and Answers
By region
What changes depending on where you live in Illinois?
Not your price or how you’re seen: care is online, and NexLife’s price is the same anywhere in Illinois. What changes is the heat at your door. In summer 2026, Carbondale reached 86°F or more, the most Zepbound’s label allows outside the fridge, on 87 of 122 days, Bloomington on 44 and Rockford on 30. Local health numbers differ too: CDC estimates adult obesity at 31.0% in Cook County and 42.1% in Macon County, against 34.0% statewide.
Tap a region on the map to see what changes there
Each dot is a region, named for its main city: tap it for the region’s people, its adults with obesity and diabetes against the state, its summer heat and a note on what changes there. Every region is in the table below too.
- 12.5 millionpeople in Illinois
- 34.0%adults with obesity
- 11.7%adults with diabetes
- 30–87summer days at 86°F or more, by region
Wherever you live in Illinois, a provider licensed to treat you here can see you online, and your medicine ships to your door.
| Region | Main cities | Adults with obesity | Days at 86°F or more |
|---|---|---|---|
| Chicago area6 counties · 8.2 million people | Chicago, Aurora, Joliet, Naperville | 31.8% | 32 of 122 hottest 96°F |
| Metro East (St. Louis area)10 counties · 707,394 people | Belleville, O’Fallon, Granite City, Edwardsville | 38.7% | 77 of 122 hottest 101°F |
| Peoria area10 counties · 508,321 people | Peoria, Pekin, East Peoria, Washington | 36.6% | 41 of 120 hottest 96°F |
| Rockford area8 counties · 599,718 people | Rockford, Loves Park, Belvidere, Machesney Park | 39.7% | 30 of 122 hottest 96°F |
| Champaign-Urbana8 counties · 404,371 people | Champaign, Urbana, Rantoul, Mahomet | 35.2% | 44 of 122 hottest 97°F |
| Springfield area14 counties · 438,825 people | Springfield, Chatham, Jacksonville, Lincoln | 39.1% | 52 of 122 hottest 100°F |
| Quad Cities (Illinois side)6 counties · 281,942 people | Moline, Rock Island, East Moline, Silvis | 38.2% | 37 of 122 hottest 96°F |
| Bloomington-Normal3 counties · 221,126 people | Bloomington, Normal, Pontiac, Clinton | 35.0% | 44 of 122 hottest 96°F |
| Southern Illinois17 counties · 337,960 people | Carbondale, Marion, Herrin, Murphysboro | 40.4% | 87 of 122 hottest 103°F |
| Kankakee area5 counties · 433,939 people | Kankakee, Bourbonnais, Bradley, Manteno | 38.9% | 36 of 122 hottest 95°F |
| Decatur area7 counties · 210,401 people | Decatur, Mount Zion, Forsyth, Maroa | 39.6% | 47 of 122 hottest 99°F |
Cost
How much does tirzepatide cost in Illinois?
Month to month, compounded tirzepatide costs $139 to $399 a month in Illinois, fees included, at the 13 of the 14 programs in our price index that sell it in Illinois (Shapely doesn’t); we checked Nov. 1, 2026. NexLife is $139 a month on the 12-month plan, $149 on 6 months, $159 on 3 months or $169 month to month, the same at every dose. Brand-name Zepbound is $299 to $449 a month at LillyDirect ($449 from 7.5 mg, with a refill within 45 days), down from $399 to $549 when Lilly began selling vials in August 2024, and its list price is $1,086.37 a month.
What a month of tirzepatide costs, 2023 to 2026
Lowest to highest monthly price for each option
- Zepbound list price2023 to 2026$1,060 to $1,086/mo
- LillyDirect vialsAug. 2024, 2.5 and 5 mg$399 to $549/mo
- LillyDirect vialsFeb. 2025; 7.5 and 10 mg need a refill within 45 days$349 to $499/mo
- LillyDirect vialsSince Dec. 2025; 7.5 mg and up need a refill within 45 days$299 to $449/mo
- Compounded tirzepatide, online13 programs that sell it in Illinois, Nov. 2026$139 to $399/mo
- NexLife, compounded12-month plan to month to month$139 to $169/mo
NexLife Price Match Guarantee†. Already on compounded tirzepatide with another licensed provider, and paying less? We match your regular monthly price. How it works · What insurance covers in Illinois
NexLife in Illinois
What NexLife offers Illinoisans
NexLife is a LegitScript-certified telehealth company. If a licensed provider prescribes it, compounded tirzepatide is $139 a month on the 12-month plan, $149 on 6 months, $159 on 3 months or $169 month to month, the same from 2.5 mg to 15 mg, with no membership fee.
- Care included. A licensed provider, a nutrition plan, a 1:1 coaching call and real people 24/7: call or text (949) 818-8000.
- Free expedited shipping. Insulated, cold-packed boxes, usually sent within 1 to 2 business days, wherever you live in Illinois.
- Ways to pay. HSA or FSA cards, Affirm, Klarna or Afterpay. Not prescribed? No charge for medication.
- Price Match Guarantee†. Switching from another licensed provider with an active prescription? We match your regular monthly price.
- Cancel by email. It takes effect 30 days after we receive it. Plans renew until you cancel.
NexLife publishes this guide. A licensed provider decides whether a prescription is right for you; finishing the health questions doesn’t mean you’ll be prescribed. Compounded tirzepatide isn’t FDA-approved, and it’s prescribed only when it offers a significant difference for you compared with an FDA-approved product.
How it works
How to get tirzepatide in Illinois, from your couch to your door
Online, in four steps, with no insurance needed. Here’s what happens at NexLife.
- Answer a few health questionsAbout 3 minutes online: your health history, your medicines and your goals.
- A licensed provider reviews themA provider licensed to treat you in Illinois decides whether compounded tirzepatide is right for you, following Illinois’s rules. You’re prescribed only if it is.
- A licensed pharmacy prepares itYour prescription goes to a partner pharmacy with the licenses Illinois requires, which usually ships within 1 to 2 business days, free.
- It comes to your doorIn an insulated, cold-packed box. Put it in the fridge right away; if it arrives warm, don’t use it: call or text (949) 818-8000.
How do you keep tirzepatide cool in an Illinois summer?
Store compounded tirzepatide the way your prescription label says, usually in the fridge at 36°F to 46°F, and get the box inside fast. Zepbound’s 21-day room-temperature rule, up to 86°F, doesn’t apply to compounded vials. Orders through NexLife ship in insulated, cold-packed boxes; if yours arrives warm, don’t use it: call or text (949) 818-8000.
On hot days, be home for delivery or pick a shaded drop-off spot, and get the box into the fridge right away. In a disaster, if your pharmacist can’t reach your prescriber, Illinois law lets them dispense an emergency supply of up to 30 days of a non-controlled medicine for a chronic condition, when stopping could harm you and that pharmacy has filled it for you before. (Illinois General Assembly) More: how to store compounded tirzepatide.
Can you get tirzepatide online in Illinois?
Yes. Illinois lets licensed providers treat you by telehealth, under the rules below. Your prescriber needs an Illinois license, and a pharmacy outside Illinois needs an Illinois license to ship to you.
Getting care online
Illinois lets licensed providers treat you by telehealth within their scope of practice, held to the same standards of care as in-person services and to federal and state privacy laws. Diagnosing or treating a patient in Illinois from another location is practicing medicine here, so the physician needs an Illinois license or permit, and out-of-state providers answer to Illinois courts.
225 ILCS 150/15 (Telehealth Act); 225 ILCS 60/49.5 (Medical Practice Act of 1987, telemedicine) · source
An Illinois license
A physician treating you in Illinois needs an Illinois license or permit, or faces penalties. Illinois is a full member of the Interstate Medical Licensure Compact, under a law effective July 20, 2015. The compact is a route to an Illinois license, not a substitute.
Made for you, not mass-produced
The FDA declared the tirzepatide shortage over on Dec. 19, 2024; an appeals court upheld that on Aug. 27, 2026. Prescribed only when it offers a significant difference for you compared with an FDA-approved product. What compounded tirzepatide is
FDA; Fifth Circuit, No. 25-10600
Nurse practitioners and PAs
Outside hospitals and similar facilities, physician assistants and newer nurse practitioners need a written collaborative agreement with a physician. Nurse practitioners can prescribe on their own after filing proof of 4,000 clinical hours and 250 hours of training.
225 ILCS 65/65-35 and 65/65-43 (Nurse Practice Act); 225 ILCS 95/7.5 (Physician Assistant Practice Act of 1987) · source
How pharmacies must ship
Out-of-state pharmacies shipping to Illinois must now have a pharmacist-in-charge licensed in Illinois. The rule began Jan. 1, 2026, and a board variance set March 30, 2026 as the deadline for existing licenses.
68 Ill. Adm. Code 1330.550; Illinois State Board of Pharmacy minutes, Jan. 13, 2026 · source
Illinois’s compounding rules
IDFPR’s spring 2025 newsletter told Illinois pharmacies that the FDA’s grace period for compounding tirzepatide had ended for state-licensed pharmacies, and that semaglutide’s ran until at least April 22, 2025.
IDFPR Compliance Capsule, Spring 2025 (relaying FDA's March 10, 2025 updates) · source
Sterile compounding rules
Illinois’s updated pharmacy rules took effect June 28, 2024. They require all compounding, sterile and nonsterile, to follow the official USP-NF standards.
68 Ill. Adm. Code 1330 (rules effective June 28, 2024) · source
“The Department shall require and provide for a nonresident pharmacy license for all pharmacies located outside of this State that dispense medications for Illinois residents and mail, ship, or deliver prescription medications into this State.”
Illinois General Assembly, 225 ILCS 85/16a, Pharmacy Practice Act: nonresident pharmacies
Does insurance cover tirzepatide in Illinois in 2026?
For weight loss alone, rarely. Illinois Medicaid covers Zepbound only for obstructive sleep apnea, not for weight loss alone. Illinois’s state employee plan covers GLP-1s for weight loss only with criteria. With Medicare Part D, the GLP-1 Bridge can bring Zepbound KwikPens to $50 a month.
Illinois Medicaid: not for weight loss
No, not for weight loss alone. Illinois Medicaid’s drug list, effective Oct. 20, 2026, covers Zepbound only for obstructive sleep apnea, as a non-preferred drug. That limit began with the Oct. 1, 2026 list; the July 1, 2026 list had no Zepbound. For type 2 diabetes, the list includes Mounjaro as non-preferred.
Illinois Department of Healthcare and Family Services, 2026-10-20
State Employees Group Insurance Program: only with criteria
Yes, with prior authorization. Illinois law (since July 1, 2024) requires the state employee program to cover medically necessary injectable weight-loss medicines for adults with obesity, prediabetes or gestational diabetes. In the OAP, QCHP and CDHP plans, Zepbound is Tier 2 with prior authorization.
State university employees (employees of the state university system): University employees get health coverage through the State Employees Group Insurance Program, so the same 2024 law on injectable weight-loss medicines applies, and the same CVS Caremark list covers the OAP, QCHP and CDHP plans.
Teachers’ Retirement Insurance Program (TRIP) (retired teachers in TRIP and their dependents): TRIP plans that use CVS Caremark share the state drug list, effective Oct. 1, 2026, which puts Zepbound and Wegovy on Tier 2 with prior authorization. TRIP HMO members should check their HMO’s own list.
Illinois General Assembly
Medicare: $50 through the GLP-1 Bridge
Eligible Part D enrollees can get the Zepbound KwikPen, the Wegovy pen and pill, or Foundayo for $50 a month, with prior authorization, from July 1, 2026, to Dec. 31, 2027. Zepbound vials aren’t included. Who qualifies
TRICARE: Prime and Select still cover weight-loss medications in certain circumstances; TRICARE For Life has excluded them since Aug. 31, 2025.
CMS, Medicare GLP-1 Bridge; TRICARE, Aug. 5, 2025
Job-based and marketplace plans: it depends on your plan
Illinois’s 2024 weight-loss medicine law is written for the state employee program. If your plan comes through work, check its drug list: ask whether Zepbound or Wegovy is covered for weight loss, what prior authorization requires, and whether a BMI cutoff applies.
If your plan says no. If an Illinois-regulated plan denies a GLP-1 as not medically necessary, you can ask the Department of Insurance for an external review within 4 months of the final denial. It’s free. Decisions come within 45 days, or 72 hours if urgent. It can’t override plan exclusions. Self-insured job plans, Medicare and Medicaid aren’t eligible.
Health Carrier External Review Act, 215 ILCS 180/15, 35, 40, 70 and 75
No insurance: cash prices
Compounded tirzepatide costs $139 to $399 a month online at the programs in our index that sell it in Illinois. Zepbound at LillyDirect is $299 at 2.5 mg, $399 at 5 mg and $449 from 7.5 mg with a refill within 45 days ($499–$699 otherwise). NexLife is $139 a month on the 12-month plan or $169 month to month, and takes HSA and FSA cards, Affirm, Klarna and Afterpay. Tirzepatide without insurance · Paying with Klarna or Afterpay
Prices checked Nov. 1, 2026
“Illinois Medicaid Preferred Drug List Effective October 20, 2026…”
Illinois Department of Healthcare and Family Services, Illinois Medicaid Preferred Drug List, effective October 20, 2026 (page 1)
How do you check a tirzepatide provider in Illinois?
In about five minutes, for free. Ask for your prescriber’s name and license and the pharmacy that will fill your prescription, then look both up on Illinois’s public license searches. A good program answers in writing. Here are the questions to ask, with NexLife’s answers.
- Get two namesYour prescriber’s, and your pharmacy’s.
- Look up the prescriberOn Illinois’s license search: a current Illinois license.
- Look up the pharmacyOn Illinois’s pharmacy license lookup: an Illinois license if it’s out of state. More
- Check the websiteLook for LegitScript certification. NexLife has it.
What changed for tirzepatide in Illinois, and when?
Nationally, the FDA declared the tirzepatide shortage over in December 2024, an appeals court upheld that in August 2026, and Medicare’s $50 GLP-1 Bridge started in July 2026. Here’s every change we found for Illinois, newest first, each with its source.
Illinois Medicaid’s current drug list takes effect; Wegovy and Zepbound still aren’t covered for weight loss alone. HFS
Illinois Medicaid’s drug list adds an anti-obesity class: Wegovy for heart risk and MASH, Zepbound for sleep apnea only. HFS
The state plans’ CVS Caremark drug list takes effect, with Zepbound and Wegovy on Tier 2 with prior authorization. CVS Caremark for the Illinois Department of Central Management Services
National: the Medicare GLP-1 Bridge starts, covering Wegovy, Foundayo and the Zepbound KwikPen for $50 a month. Medicare.gov
Deadline for out-of-state pharmacies shipping to Illinois to have a pharmacist-in-charge licensed in Illinois. IDFPR
FDA update, relayed by IDFPR to Illinois pharmacies: the tirzepatide compounding grace period for pharmacies has ended. IDFPR
National: the FDA declares the tirzepatide injection shortage resolved. U.S. Food and Drug Administration
How many units is your tirzepatide dose?
It depends on your vial’s strength. Here are the doses on Zepbound’s label at one example strength, with the math to check your own.
| Dose | mL at 25 mg/mL | Units (U-100) | On the label |
|---|---|---|---|
| 2.5 mg | 0.1 mL | 10 units | Starting dose, for 4 weeks |
| 5 mg | 0.2 mL | 20 units | A maintenance dose |
| 7.5 mg | 0.3 mL | 30 units | A step up |
| 10 mg | 0.4 mL | 40 units | A maintenance dose |
| 12.5 mg | 0.5 mL | 50 units | A step up |
| 15 mg | 0.6 mL | 60 units | The maximum, and a maintenance dose |
The math: mL = dose ÷ strength (mg per mL), and units = mL × 100. At 25 mg/mL, 10 mg is 10 ÷ 25 = 0.4 mL, or 40 units.
25 mg per mL is an example only: it’s the strength of the 15 mg multi-dose vial on Zepbound’s label (15 mg per 0.6 mL). Read the strength on your own vial’s label; your provider sets your dose, in steps at least 4 weeks apart. Every step: the tirzepatide dosage chart.
Two medications. One flat price at every dose.
No membership fee. Your provider, a nutrition plan, coaching and shipping are included.
12-month plan $139/mo
Tirzepatide
Weekly and dual-action. $169/mo month to month.
Check my eligibilityCompounded, not FDA-approved · Not prescribed? No charge for medication
12-month plan $119/mo
Semaglutide
Weekly GLP-1. $139/mo month to month.
Check my eligibilityCompounded, not FDA-approved · Not prescribed? No charge for medication
Compounded, not FDA-approved; prescribed only when it offers a significant difference for you compared with an FDA-approved product. Vials are illustrations. Every plan and price · Price Match Guarantee† terms
The NexLife Price Match Guarantee†
Keep your price. Upgrade your care.
Already on compounded tirzepatide or semaglutide? Pay less with another licensed provider, and we match your regular monthly price while your plan stays active.† Plus a provider who follows your dose, a nutrition plan, a coaching call and real people 24/7.
- 1Send a receipt from the last 60 days
- 2A NexLife provider reviews your prescription
- 3Pay your matched price, at every dose
Locked while your plan is activeSame price at every doseNo membership fee
†New members switching with an active prescription. Terms: see the Price Match Guarantee† details below.
Tirzepatide in Illinois: your questions
Fair questions about NexLife
- Will my price go up with my dose?
- No. You pay the same at every dose.
- What if I’m not prescribed?
- You aren’t charged for medication.
- Can I cancel?
- Yes, by email. It takes effect 30 days after we receive it. Plans renew until you cancel; our cancellation policy has the details.
- Do I need insurance?
- No. Pay with an HSA or FSA card, or with Affirm, Klarna or Afterpay at checkout.
Who are the best tirzepatide providers in Illinois?
It depends on what you need. NexLife keeps one price at every dose with care included ($139 a month on the 12-month plan or $169 month to month), PreventiveMD has the lowest month-to-month compounded price we found ($139), Mochi Health offers obesity-medicine doctors, and LillyDirect sells FDA-approved Zepbound, $299 at the starting dose. NexLife publishes this guide.
Does Illinois Medicaid cover Zepbound for weight loss?
No. Illinois Medicaid’s drug list, effective Oct. 20, 2026, says Zepbound won’t be covered for weight loss alone. It covers Zepbound only for obstructive sleep apnea, as a non-preferred drug, a limit that began with the Oct. 1, 2026 list. For type 2 diabetes, the list includes Mounjaro, also non-preferred. Ask your health plan what approval it needs.
Does the Illinois state employee plan cover Zepbound?
Yes, with prior authorization. Since July 1, 2024, Illinois law has required the state employee program to cover medically necessary injectable weight-loss medicines for adults with obesity, prediabetes or gestational diabetes. The CVS Caremark list for the OAP, QCHP and CDHP plans puts Zepbound on Tier 2 with prior authorization. You may need to join a lifestyle program.
Is compounded tirzepatide legal in Illinois?
Yes, when a licensed prescriber orders it for you and a licensed pharmacy compounds it. The FDA declared the tirzepatide shortage over on Dec. 19, 2024, so pharmacies can’t keep making routine copies. A provider prescribes it only when it offers a significant difference for you compared with an FDA-approved product. Compounded tirzepatide isn’t FDA-approved.
Does my prescriber need an Illinois license to prescribe tirzepatide online?
Yes. Illinois treats diagnosing or treating a patient located in Illinois from another place as practicing medicine, so the physician needs an Illinois license or permit. Illinois joined the Interstate Medical Licensure Compact with a law effective July 20, 2015, but the compact only leads to an Illinois license. Check any prescriber on IDFPR’s license lookup.
Can a pharmacy in another state ship tirzepatide to Illinois?
Yes, if Illinois has licensed it. An out-of-state pharmacy needs an Illinois nonresident pharmacy license to mail prescriptions here, must follow Illinois pharmacy law for Illinois patients and must print a toll-free pharmacist number on each label. Since March 30, 2026, its pharmacist-in-charge must hold an Illinois license. You can check the pharmacy on IDFPR’s license lookup.
How do I keep tirzepatide cold in an Illinois summer?
Refrigerate it as soon as it arrives and follow the label. In summer 2026, O’Hare hit 86°F or more on 32 of 122 days, Springfield on 52, and St. Louis Lambert, the Metro East’s airport, on 77, peaking at 101°F. Be home for deliveries on hot days. If a vial arrives warm, don’t use it: NexLife patients call or text (949) 818-8000.
How much does tirzepatide cost in Illinois without insurance?
Online, compounded tirzepatide costs $139 to $399 a month, all in, with a median of $237 (checked Nov. 1, 2026). Zepbound from LillyDirect is $299 to $449 a month; $449 from 7.5 mg needs a refill within 45 days, or it’s $499 to $699. At NexLife, it’s $139 a month on the 12-month plan or $169 month to month.
In your state
Not in Illinois? Pick your state
Tap your state on the map for its guide.
Illinois (you’re here): compounded tirzepatide is available through NexLife, $139/mo on the 12-month plan or $169 month to month, the same at every dose.
Compounded medications aren’t FDA-approved. A licensed provider prescribes one only when it offers a significant difference for you compared with an FDA-approved product.
Rules, coverage and prices by state →
Every NexLife state guide
Tirzepatide: Arizona · Arkansas · California · Colorado · Connecticut · Florida · Georgia · Idaho · Indiana · Iowa · Maine · Maryland · Massachusetts · Michigan · Minnesota · Nebraska · New Hampshire · New Jersey · New York · North Carolina · Ohio · Oklahoma · Oregon · Pennsylvania · South Carolina · Tennessee · Texas · Utah · Virginia · Washington · Wisconsin
Semaglutide: Arizona · California · Colorado · Florida · Georgia · Illinois · Indiana · Maryland · Massachusetts · Michigan · Minnesota · New York · North Carolina · Ohio · Oregon · Pennsylvania · South Carolina · Tennessee · Texas · Virginia · Washington · Wisconsin
Important safety information
Compounded tirzepatide and semaglutide are not FDA-approved, and the FDA hasn’t reviewed them for safety, effectiveness or quality. A provider prescribes them only when they offer a significant difference for you compared with an FDA-approved product.
Both medicines may cause thyroid tumors, including cancer: don’t use either if you or a family member has had medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2). Read the full safety information
In studies with rodents, both medicines caused thyroid tumors; it isn’t known whether they cause them in people. Tell your provider if you notice a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath. Serious side effects can include inflammation of the pancreas (pancreatitis), gallbladder problems, low blood sugar (especially with insulin or sulfonylureas), kidney problems from dehydration, severe stomach problems, serious allergic reactions, vision changes in people with type 2 diabetes, and a faster heart rate. Tell your care team before any surgery or procedure that uses anesthesia or deep sedation. Don’t combine either medicine with other GLP-1 medicines.
Tirzepatide can make birth control pills less effective: switch to a non-oral method, or add a barrier method such as condoms, for 4 weeks after you start and for 4 weeks after each dose increase. Both medicines may harm an unborn baby. Semaglutide should be stopped at least 2 months before a planned pregnancy. Tell your provider right away if you’re pregnant, planning to be, or breastfeeding.
This is a summary, not the complete safety information. Read the full Prescribing Information for FDA-approved tirzepatide (Zepbound) and semaglutide (Wegovy), and talk with your provider. You can report side effects to the FDA at 1-800-FDA-1088 or fda.gov/medwatch.
Who wrote and checked this page
NexLife Medical Team
NexLife’s clinical team, led by medical director Adam Kennah, MD. The team writes and reviews NexLife’s guides, checks every price and rule against its source, and dates each check.
Adam Kennah, MD
Medical Director, NexLife. Board-certified in emergency medicine (American Board of Emergency Medicine). NPI 1144260043. Leads the NexLife clinical team, which medically reviews each of NexLife’s guides, including this one.
How we checked. On Nov. 1, 2026, we read each program’s public pages (no quiz, account or checkout); on Nov. 2, 2026, we read Illinois’s Medicaid, licensing, telehealth and pharmacy rules at their sources. The heat counts are ours, from NOAA’s daily station data at 11 weather stations.
How we make money. We earn revenue when people join NexLife, one of the programs here, so we name the catch for every option, ours included.
Corrections. See something wrong or out of date? Email care@nexlife.us and we’ll fix it.
Sources
38, tap to open
- NOAA Regional Climate Centers (ACIS). Daily maximum temperatures, June 1 to September 30, 2026.
- Illinois Department of Healthcare and Family Services (HFS). Illinois Medicaid Preferred Drug List, effective October 20, 2026 (page 36 of 146: "ANTI-OBESITY : GIP & GLP-1 RECEPTOR AGONISTS"). 2026-10-20.
- NexLife. GLP-1 price index. Checked Nov. 1, 2026.
- Hims. Zepbound through Hims. Checked Nov. 1, 2026.
- LillyDirect. Zepbound self-pay prices. Checked Nov. 1, 2026.
- Eli Lilly. Lilly lowers the price of Zepbound single-dose vials. Dec. 1, 2025.
- Ro. Weight loss pricing. Checked Nov. 1, 2026.
- Centers for Medicare & Medicaid Services. Medicare GLP-1 Bridge, overview and FAQs.
- Centers for Disease Control and Prevention. PLACES: County Data, 2025 release (adult obesity and diabetes; Census 2023 population).
- Illinois General Assembly (Illinois Compiled Statutes, official ilga.gov copy). 225 ILCS 85/15.3, Pharmacy Practice Act: Emergency prescription refills. Source: P.A. 100-237, eff. 8-18-17.
- Eli Lilly and Company. Zepbound (tirzepatide) prescribing information.
- Illinois General Assembly (Illinois Compiled Statutes, official ilga.gov copy). 225 ILCS 150/15, Telehealth Act: Use of telehealth services. Source: P.A. 102-104, eff. 7-22-21; 102-1117, eff. 1-13-23.
- Illinois General Assembly (Illinois Compiled Statutes, official ilga.gov copy). 225 ILCS 60/49.5, Medical Practice Act of 1987: Telemedicine (repeal date shown: January 1, 2032).
- Illinois General Assembly (Illinois Compiled Statutes, official ilga.gov copy). 45 ILCS 180, Interstate Medical Licensure Compact Act (act summary and Sec. 99). P.A. 99-76, eff. 7-20-15.
- U.S. Food and Drug Administration. FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize.
- U.S. Court of Appeals for the Fifth Circuit. Outsourcing Facilities Association v. FDA, No. 25-10600 (Aug. 27, 2026).
- Illinois General Assembly (Illinois Compiled Statutes, official ilga.gov copy). 225 ILCS 65/65-43, Nurse Practice Act: Full practice authority. Source: P.A. 102-75, eff. 1-1-22; 103-60, eff. 1-1-24.
- Illinois General Assembly (Illinois Compiled Statutes, official ilga.gov copy). 225 ILCS 65/65-35, Nurse Practice Act: Written collaborative agreements. Source: P.A. 104-244, eff. 1-1-26.
- IDFPR, Compliance Capsule quarterly newsletter (reprints 68 Ill. Adm. Code 1330.550). Compliance Capsule, Fall 2024: "Section 1330.550 Nonresident Pharmacies". Fall 2024.
- Illinois State Board of Pharmacy (IDFPR). Board of Pharmacy open session minutes, January 13, 2026 ("Nonresident Pharmacies Pharmacist-In-Charge"). 2026-01-13.
- Illinois Department of Financial and Professional Regulation (IDFPR). Compliance Capsule, Spring 2025: "Tirzepatide Compounding Update" (relaying FDA's March 10, 2025 update). Spring 2025.
- Illinois General Assembly (Illinois Compiled Statutes, official ilga.gov copy). 225 ILCS 85/16a, Pharmacy Practice Act: nonresident pharmacies. Source: P.A. 100-497, eff. 9-8-17.
- U.S. Food and Drug Administration. Compounding and the FDA: questions and answers.
- Eli Lilly and Company (release on Drugs.com). FDA approves Lilly’s Zepbound (tirzepatide) for chronic weight management. Nov. 8, 2023.
- Eli Lilly and Company. Zepbound list and direct-to-patient prices. Read Oct. 30, 2026.
- Eli Lilly and Company. Lilly releases Zepbound single-dose vials, expanding supply and access. Aug. 27, 2024.
- Eli Lilly and Company. Lilly launches additional Zepbound vial doses and offers new savings for self-pay patients. Feb. 25, 2025.
- Illinois General Assembly (Illinois Compiled Statutes, official ilga.gov copy). 5 ILCS 375/6.11C, State Employees Group Insurance Act of 1971: Coverage for injectable medicines to improve glucose or weight loss.
- Illinois Department of Central Management Services (CMS), Bureau of Benefits. Bureau of Benefits (program descriptions). Checked 2026-11-02.
- Illinois Department of Central Management Services (CMS), Bureau of Benefits. TRIP Prescription Plan (links the same State of Illinois formulary). Checked 2026-11-02.
- TRICARE. TRICARE coverage of weight loss medications: what to know (Aug. 5, 2025).
- Illinois General Assembly (Illinois Compiled Statutes, official ilga.gov copy). 215 ILCS 180/35, Health Carrier External Review Act: Standard external review. Source: P.A. 102-579, eff. 1-1-22.
- LegitScript. Certification record for nexlife.us.
- Illinois Department of Healthcare and Family Services (HFS). Illinois Medicaid Preferred Drug List, effective October 1, 2026 (page 36: first list with the anti-obesity class). 2026-10-01.
- CVS Caremark for the Illinois Department of Central Management Services (formulary linked from CMS benefit pages). Central Management Services (CMS) - State Employee Health Plan Formulary, 2026 List of Covered Drugs (cover page; lists SEGIP, Local, CIP and TRIP contacts). Effective 10/01/2026 (last updated 10/01/2026).
- Centers for Medicare & Medicaid Services (Medicare.gov). Medicare GLP-1 Bridge: GLP-1 Drugs for $50 a Month (CMS Product No. 12234). June 2026.
- NexLife. How to store compounded tirzepatide.
- Each provider’s own pricing page, linked in the comparison table above; every program in our index is linked from the GLP-1 price index.
Keep reading
†NexLife Price Match Guarantee: for new NexLife members switching from a licensed U.S. telehealth provider or clinic with an active prescription for compounded tirzepatide or semaglutide. We match your regular all-in monthly price there (medication plus any required membership, program or visit fee, on a month-to-month plan); first-month offers, coupons, referral credits and prepaid multi-month rates aren’t matched. Proof from the last 60 days required. A licensed provider must determine that treatment is right for you. Not open to people with Medicare, Medicaid or TRICARE coverage. Full terms.
Paying less elsewhere? We match it.†
One price at every dose.
Start online in about 3 minutes. From Chicago and Aurora to Rockford and Springfield, you can start online and, if a provider prescribes it, have it shipped to your door.
4.8 out of 5 on Trustpilot · Medical director Adam Kennah, MD (NPI 1144260043) · LegitScript-certified
Compounded medications aren’t FDA-approved. A licensed provider prescribes one only when it offers a significant difference for you compared with an FDA-approved product.